<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Ultivue — Prospect Detail</title>
  <link rel="stylesheet" href="styles.css">
</head>
<body>
<header class="site-header"><h1>Prospect Detail</h1></header>
<div class="container">
  <a href="index.html" class="back-link">&larr; Back to All Prospects</a>
  <div class="detail-header">
    <span class="badge health" style="font-size:.8rem;">Digital Health</span>
    <h1>89. Ultivue</h1>
    <p class="meta">DNA-PAINT Imaging Technology</p>
  </div>
  <div class="section"><h3>1. Startup Name</h3><p><strong>Ultivue</strong></p></div>
  <div class="section"><h3>2. Founder Contact</h3><p><strong>Wyss Institute Team</strong></p><p>Wyss Institute for Biologically Inspired Engineering at Harvard</p><p>Founded on DNA-PAINT super-resolution imaging technology</p></div>
  <div class="section"><h3>3. Product Overview</h3><p>Ultivue develops innovative imaging solutions using DNA-PAINT technology. The platform enables high-resolution multiplexed tissue imaging for cancer research and diagnostics, allowing researchers to visualize multiple biomarkers simultaneously with unprecedented clarity.</p></div>
  <div class="section"><h3>4. Funding Stage</h3><p><strong>Series B</strong> — Raised significant venture funding for product development and commercialization.</p></div>
  <div class="section"><h3>5. How I Found the Company</h3><p>Discovered through Wyss Institute spinout company portfolio and precision medicine coverage.</p></div>
  <div class="strengths-weaknesses">
    <div class="section"><h3>Strengths</h3><ul><li><strong>Technology leadership:</strong> DNA-PAINT offers unique advantages for multiplexed imaging.</li><li><strong>Growing market:</strong> Spatial biology market projected to exceed $1B by 2027.</li></ul></div>
    <div class="section"><h3>Weaknesses</h3><ul><li><strong>Competitive field:</strong> Akoya, Nanostring, and others compete in spatial biology.</li><li><strong>Academic adoption:</strong> Research tools have long adoption cycles.</li></ul></div>
  </div>
  <div class="section"><h3>7. Five Questions for the Team</h3><ol class="questions-list"><li>How many biomarkers can you image simultaneously?</li><li>What pharma and academic partnerships have you established?</li><li>How do you compare to competing spatial biology platforms?</li><li>What is your commercial traction in the pharmaceutical market?</li><li>Are you expanding into clinical diagnostics applications?</li></ol></div>
  <a href="index.html" class="back-link">&larr; Back to All Prospects</a>
</div>
</body>
</html>
